Amrita Krishnan, M.D. Director of the Judy and Bernard Briskin Center for Multiple Myeloma Research Director, Multiple Myeloma Program Associate Director, Medical Education & Training Program Professor, Department of Hematology & Hematopoietic Cell Transplantation, City Of Hope, Discusses Details On The SWOG1803 Trial. At MOASC Oncology Summit On Feb 23, 2019.
For More Info Visit: https://moasc.org
Advertisement